Large study checks safety of new whooping cough shot
NCT ID NCT07400120
Summary
This study was conducted to monitor the safety of the VacPertagen whooping cough vaccine after it was approved for use in Thailand. Over 5,400 people were observed by their doctors and nurses to track any side effects, especially in pregnant women and their babies. The goal was to ensure the vaccine is safe for the general public in real-world conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERTUSSIS (WHOOPING COUGH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BioNet-Asia Co.,Ltd.
Bangkok, Bangkok, 10260, Thailand
Conditions
Explore the condition pages connected to this study.